IB

Ilan Ben Cnaan

Director Director DIN 02206576
DIN 02206576 First appointment Jun 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2008
Shareholding value Locked Premium profile

About Ilan Ben Cnaan

Data last updated:

Ilan Ben Cnaan has 18 years in corporate governance. Formerly with 1 company, such as Biopharmax India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02206576
Primary Designation Director
First Appointment 30 Jun 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Biopharmax India Private Limited U45201PN2006FTC138676
Director30 Jun 20082006Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biopharmax India Private Limited
Premium access

Shareholding and investment profile for Ilan Ben Cnaan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ilan Ben Cnaan

Ilan Ben Cnaan has 18 years in corporate governance. Formerly with 1 company, such as Biopharmax India Private Limited. Engaged in General Business. Contributes to corporate operations.

Ilan Ben Cnaan is associated with 0 companies as a director.

Ilan Ben Cnaan has expertise in General Business.

Ilan Ben Cnaan has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available